10 Brand Blunders…And How to Avoid Them
May 10, 2005Sales and Marketing
1) Stay loyal to the core brand message and never undermine itIt may have seemed a good idea at the …
Stepping out: the contract salesforce
May 10, 2005Sales and Marketing
Sales forces in the pharmaceutical industry account for around 75% of marketing budgets, and are coming under increasing pressure to …
Gilmartin to leave troubled Merck
May 6, 2005Sales and Marketing
Raymond Gilmartin has stood down as chief executive and chairman of Merck, drawing a line under long-running uncertainty regarding the …
GSK makes strategic biotech acquisition
May 6, 2005Research and Development, Sales and Marketing GSK, biotech
GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …
Crestor sales top $1 billion for AstraZeneca
May 6, 2005Sales and Marketing
AstraZeneca's Crestor has achieved blockbuster status, despite continuing concerns over its safety, registering sales of over $1 billion for the …
Lilly’s first-in-class diabetes drug approved in US
May 5, 2005Sales and Marketing
Lilly has gained US marketing approval for Byetta, the first in a new class of type II diabetes treatments derived …
Mixed news for AstraZeneca’s stroke drug Cerovive
May 4, 2005Research and Development, Sales and Marketing
AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …
Does your brand need a check-up?
May 4, 2005Sales and Marketing
Brands are all about 'adding value'. To provide this value to our target customers we need to ensure we have …
Filling in the gaps in your team
May 4, 2005Business Services
Outsourcing as an integral element of a business strategy has waxed and waned in popularity and acceptability over the last …
Taking on the market leader
May 4, 2005Sales and Marketing
Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …
Velcade moves up to second line treatment
April 28, 2005Sales and Marketing
Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …
EMEA advises against prescribing of antidepressants in children
April 28, 2005Sales and Marketing
Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …
Strattera sales fall back over continuing safety concerns
April 26, 2005Sales and Marketing
Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD …
Woolley Pau wins Novo Nordisk insulin accounts
April 26, 2005Medical Communications
Following a four-way pitch, Convent Garden-based advertising agency Woolley Pau has been appointed by Novo Nordisk to work on its …
MHRA failing patients, warns report
April 26, 2005Sales and Marketing
MPs have called for an urgent review of the UK drugs regulator, saying that tougher regulation of the industry is …
Super surgeries become an election issue
April 26, 2005Labour plans to create 'super surgeries' designed to grant "entrepreneurial" GPs the opportunity to broaden their scope and offer patients …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
